Abbott Laboratories (ABT)
(Delayed Data from NYSE)
$103.43 USD
+0.56 (0.54%)
Updated Jun 4, 2024 04:00 PM ET
After-Market: $103.05 -0.38 (-0.37%) 6:24 PM ET
3-Hold of 5 3
C Value C Growth B Momentum C VGM
Brokerage Reports
0 items in cart
Abbott Laboratories [ABT]
Reports for Purchase
Showing records 521 - 527 ( 527 total )
Company: Abbott Laboratories
Industry: Medical - Drugs
Company: Abbott Laboratories
Industry: Medical - Drugs
Solid Q4 Performance, On-Target 2010 Guidance, and Lots of Moving Parts to Sort Through as a New Year Begins
Provider: WEDBUSH SECURITIES INC.
Company: Abbott Laboratories
Industry: Medical - Drugs
Company: Abbott Laboratories
Industry: Medical - Drugs
December Quarter Review and 2010 Preview: The Graying of the Cardiac Devices Market
Provider: WEDBUSH SECURITIES INC.
Company: Abbott Laboratories
Industry: Medical - Drugs
Company: Abbott Laboratories
Industry: Medical - Drugs
A Very Well-Timed Approval for XIENCE in Japan - Launch Likely to Get a Big Lift from Lancet Article (COMPARE), Pending NEJM Article (SPIRIT IV)
Provider: WEDBUSH SECURITIES INC.
Company: Abbott Laboratories
Industry: Medical - Drugs
New Spotlight on XIENCE vs. TAXUS Comparison Likely to Boost ABT, Hurt BSX
Provider: WEDBUSH SECURITIES INC.